Clinical Trial Update: Dose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study assessing safety, pharmacokinetics, and pharmacodynamics of ISU304/CB2679d in adults with Hemophilia B; study completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• ISU304/CB2679d

Snippet

Sponsor: ISU Abxis Co., Ltd. | Conditions: Hemophilia B | Phase 1 | Status: COMPLETED | Results posted: 2020-11-10